Does Rallies show Form 4 insider transactions for CPIX?

Yes. Rallies tracks CPIX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CPIX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CPIX. It does not provide personalized investment advice.

CPIX (Cumberland Pharmaceuticals Inc) Stock Analysis - Insider Trades

Cumberland Pharmaceuticals Inc (CPIX) is a publicly traded Healthcare sector company. As of May 21, 2026, CPIX trades at $5.47 with a market cap of $76.71M and a P/E ratio of -11.37. CPIX moved +0.00% today. Year to date, CPIX is +38.25%; over the trailing twelve months it is +9.94%. Its 52-week range spans $1.04 to $7.25. Rallies surfaces CPIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CPIX stock inside the company?

Recent CPIX insider activity includes Young Caroline bought 6, Jones James bought 13, KAZIMI A J bought 13, Krogulski Kenneth bought 68, and Young Caroline bought 6. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CPIX Key Metrics

Key financial metrics for CPIX
Metric	Value
Price	$5.47
Market Cap	$76.71M
P/E Ratio	-11.37
EPS	$-0.49
Dividend Yield	0.00%
52-Week High	$7.25
52-Week Low	$1.04
Volume	1.63K
Avg Volume	0
Revenue (TTM)	$41.94M
Net Income	$-7.40M
Gross Margin	82.89%

Recent CPIX Insider Trades

Young Caroline bought 6 (~$20.7) on Aug 29, 2025.
Jones James bought 13 (~$44.85) on Aug 29, 2025.
KAZIMI A J bought 13 (~$44.85) on Aug 29, 2025.
Krogulski Kenneth bought 68 (~$234.6) on Aug 29, 2025.
Young Caroline bought 6 (~$20.82) on Aug 28, 2025.

Latest CPIX News

Cumberland Pharmaceuticals Reports Q1 $3.3M Loss and $100M Apotex Brand Sale — May 5, 2026
Cumberland Pharmaceuticals Sells Branded Drugs to Apotex for $100 Million Cash — Apr 23, 2026
Cumberland Q4 Revenues Jump 31% to $13.7M as Talicia Drives Growth — Mar 10, 2026
Cumberland Pharmaceuticals Posts 31% Q4 Revenue Growth to $13.7M and Cuts Credit — Mar 4, 2026
Cumberland and RedHill Begin Joint U.S. Rollout of Talicia With $4M Investment — Feb 25, 2026

CPIX Analyst Consensus

CPIX analyst coverage data. Average price target: $0.00.

Common questions about CPIX

Who is trading CPIX stock inside the company?: Recent CPIX insider activity includes Young Caroline bought 6, Jones James bought 13, KAZIMI A J bought 13, Krogulski Kenneth bought 68, and Young Caroline bought 6. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CPIX?: Yes. Rallies tracks CPIX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CPIX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CPIX. It does not provide personalized investment advice.